1. Corrigendum to 'Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)' [European Journal of Cancer 169 (2022) 1–9]. (January 2023) Authors: Li, Jiarui; Cheng, Yuejuan; Bai, Chunmei; Xu, Jianming; Shen, Lin; Li, Jie; Zhou, Zhiwei; Li, Zhiping; Chi, Yihebali; Yu, Xianjun; Li, Enxiao; Xu, Nong; Liu, Tianshu; Lou, Wenhui; Bai, Yuxian; Yuan, Xianglin; Wang, Xiuwen; Yuan, Ying; Chen, Jia; Guan, Sha Journal: European journal of cancer Issue: Volume 178(2023) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis. (25th March 2023) Authors: Xing, Jiazhang; Chen, Jingci; You, Tingting; Sun, Zhao; Lu, Tao; Cheng, Yuejuan; Wu, Huanwen; Bai, Chunmei Journal: Journal of neuroendocrinology Issue: Volume 35:Number 4(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extensive Tumor Thrombosis of Portal Venous System Demonstrated on 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in a Patient With Well-Differentiated Neuroendocrine Tumor. (November 2020) Authors: Zhu, Wenjia; Cheng, Yuejuan; Ding, Ning; Huo, Li Journal: Clinical nuclear medicine Issue: Volume 45:Number 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep). (July 2022) Authors: Li, Jiarui; Cheng, Yuejuan; Bai, Chunmei; Xu, Jianming; Shen, Lin; Li, Jie; Zhou, Zhiwei; Li, Zhiping; Chi, Yihebali; Yu, Xianjun; Li, Enxiao; Xu, Nong; Liu, Tianshu; Lou, Wenhui; Bai, Yuxian; Yuan, Xianglin; Wang, Xiuwen; Yuan, Ying; Chen, Jia; Guan, Sha Journal: European journal of cancer Issue: Volume 169(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of antagonist peptides and chelators on the diagnostic performance of PET/CT using gallium-68–labeled somatostatin receptor antagonists. Issue 1 (11th October 2022) Authors: Xing, Haiqun; Zhu, Wenjia; Cheng, Yuejuan; Yang, Qiao; Jia, Ru; Zhao, Hong; Bai, Chunmei; Huo, Li; Wu, Wenming Journal: Journal of pancreatology Issue: Volume 6:Issue 1(2023) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patients with non‐functional metastatic G2 pancreatic neuroendocrine tumor benefit from palliative surgery: A 20‐year single‐center retrospective analysis. (13th November 2022) Authors: You, Tingting; Tang, Hui; Xu, Xiuxiu; Ying, Hongyan; Sun, Zhao; Cheng, Yuejuan; Bai, Chunmei Journal: Journal of neuroendocrinology Issue: Volume 34:Number 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Perineural Invasion as a Prognostic Factor in Laryngeal Squamous Cell Cancer: A Matched-Pair Survival Analysis. (21st October 2021) Authors: Zhu, Xiaoli; Duan, Fei; Zhu, Yingying; Shi, Xiaohua; Sun, Shuai; Cheng, Yuejuan; Chen, Xingming Journal: Cancer investigation Issue: Volume 39:Number 9(2021) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study. Issue 11 (November 2020) Authors: Xu, Jianming; Shen, Lin; Bai, Chunmei; Wang, Wei; Li, Jie; Yu, Xianjun; Li, Zhiping; Li, Enxiao; Yuan, Xianglin; Chi, Yihebali; Yin, Yongmei; Lou, Wenhui; Xu, Nong; Bai, Yuxian; Zhang, Tao; Xiu, Dianrong; Wang, Xiuwen; Yuan, Ying; Chen, Jia; Qin, Shukui Journal: Lancet oncology Issue: Volume 21:Issue 11(2020) Page Start: 1489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Systemic treatment of a metastatic carotid body tumor: A case report and literature review. Issue 47 (20th November 2020) Authors: Xing, Jiazhang; Cheng, Yuejuan; Ying, Hongyan; Guan, Mei; Jia, Ning; Bai, Chunmei Other Names: Saranathan. Maya section editor. Journal: Medicine Issue: Volume 99:Issue 47(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗